CoChat

Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma

Open access
Girard, N., Sima, C.S., Jackman, D.M., Sequist, L.V., Chen, H., Yang, J.C-H., Ji, H., Waltman, B., Rosell, R., Taron, M., Zakowski, M.F., Ladanyi, M., Riely, G., Pao, W. · 2012 · European Respiratory Journal
Cited by 112

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Epidermal growth factor receptor (EGFR) tumour genotyping is crucial to guide treatment decisions regarding the use of EGFR tyrosine kinase inhibitors in nonsmall cell lung cancer (NSCLC). However, some patients may not be able to obtain tumour testing, either because tissue is limited and/or tests are not routinely offered. Here, we aimed to build a model-based nomogram to allow for prediction of the presence of EGFR mutations in NSCLC. We retrospectively collected clinical and pathological data on 3,006 patients with NSCLC who had their tumours genotyped for EGFR mutations at five institutions worldwide. Variables of interest were integrated in a multivariate logistic regression model. In the 2,392 non-Asian patients with lung adenocarcinomas, the most important predictors of harbouring EGFR mutation were: lower tobacco smoking exposure (OR 0.41, 95% CI 0.37–0.46), longer time interval between smoking cessation and diagnosis (OR 2.19, 95% CI 1.71–2.80), advanced stage (OR 1.58, 95% CI 1.18–2.13), and papillary (OR 4.57, 95% CI 3.14–6.66) or bronchioloalveolar (OR 2.84, 95% CI 1.98–4.06) histologically predominant subtype. A nomogram was established and showed excellent discriminating accuracy: the concordance index on an independent validation dataset was 0.84. As clinical practices transition to incorporating genotyping as part of routine care, this nomogram could be highly useful to predict the presence of EGFR mutations in lung adenocarcinoma in non-Asian patients when mutational profiling is not available or possible.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1183/09031936.00010111

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 112

Metadata

Authors
Girard, N., Sima, C. S., Jackman, D. M., Sequist, L. V., Chen, H., Yang, J. C.-H., Ji, H., Waltman, B., Rosell, R., Taron, M., Zakowski, M. F., Ladanyi, M., Riely, G., & Pao, W.
Venue
European Respiratory Journal
Published
2011-07-20
Volume
39
Issue
2
Pages
366-372
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W2126491616
Cited by
112
References
7
FWCI
6.19
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma. https://app.cochat.ai/papers/10.1183/09031936.00010111
The paper
Girard, N., Sima, C. S., Jackman, D. M., Sequist, L. V., Chen, H., Yang, J. C.-H., Ji, H., Waltman, B., Rosell, R., Taron, M., Zakowski, M. F., Ladanyi, M., Riely, G., & Pao, W. (2012). Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma. European Respiratory Journal. https://doi.org/10.1183/09031936.00010111

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.